Table 3.
Visit | ||||||
Screening | Randomisation | Phone Follow-up | Phone Follow-up | Follow-up | End | |
Activity | 0 | Within 30 days | 1–3 days | 15±3 | 30±3 | 90±3 |
Written consent | ✔ | |||||
Demographics | ✔ | |||||
Medical history | ✔ | ✔ | ✔ | ✔ | ||
Medications | ✔ | ✔ | ✔ | ✔ | ||
Physical exam | ✔ | ✔ | ✔ | |||
NIH Stroke Scale | ✔ | ✔ | ✔ | ✔ | ||
Hachinski ischaemic score | ✔ | |||||
MoCA | ✔ | ✔ | ✔ | ✔ | ||
Bristol Activities of Daily Living Scale | ✔ | ✔ | ✔ | ✔ | ||
AD8 Informant Questionnaire | ✔ | |||||
IQCODE | ✔ | |||||
Inclusion/Exclusion criteria | ✔ | |||||
RIC device provision | ✔ | |||||
RIC device training | ✔ | ✔ | ✔ | ✔ | ||
Subject diary provision | ✔ | |||||
Subject diary review | ✔ | ✔ | ||||
Adherence (device print out) | ✔ | ✔ | ||||
Randomisation | ✔ | |||||
Cognitive tests | ✔ | ✔ | ✔ | |||
MBI checklist | ✔ | ✔ | ✔ | |||
Blood draw | ✔ | ✔ | ✔ | ✔ | ||
MRI | ✔ | ✔ | ✔ |
MBI checklist, mild behavioural impairment checklist; MoCA, Montreal Cognitive Assessment; NIH, National Institutes of Health; RIC, remote ischaemic conditioning.